324 results on '"Miloso, Mariarosaria"'
Search Results
2. Neurodegeneration: can metabolites from Eremurus persicus help?
- Author
-
Cavalloro, Valeria, primary, Marchesi, Nicoletta, additional, Linciano, Pasquale, additional, Rossi, Daniela, additional, Campagnoli, Lucrezia Irene Maria, additional, Fossati, Alice, additional, Ahmed, Karzan Mahmood, additional, Malacrida, Alessio, additional, Miloso, Mariarosaria, additional, Mazzeo, Giuseppe, additional, Abbate, Sergio, additional, Longhi, Giovanna, additional, Ambrosio, Francesca Alessandra, additional, Costa, Giosuè, additional, Alcaro, Stefano, additional, Pascale, Alessia, additional, Martino, Emanuela, additional, and Collina, Simona, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
- Author
-
Malacrida, Alessio, primary, Deschamps-Wright, Marie, additional, Rigolio, Roberta, additional, Cavaletti, Guido, additional, and Miloso, Mariarosaria, additional
- Published
- 2023
- Full Text
- View/download PDF
4. From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
- Author
-
Listro, Roberta, primary, Malacrida, Alessio, additional, Ambrosio, Francesca Alessandra, additional, Rossino, Giacomo, additional, Di Giacomo, Marcello, additional, Cavalloro, Valeria, additional, Garbagnoli, Martina, additional, Linciano, Pasquale, additional, Rossi, Daniela, additional, Cavaletti, Guido, additional, Costa, Giosuè, additional, Alcaro, Stefano, additional, Miloso, Mariarosaria, additional, and Collina, Simona, additional
- Published
- 2022
- Full Text
- View/download PDF
5. From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
- Author
-
Listro, R, Malacrida, A, Ambrosio, F, Rossino, G, Di Giacomo, M, Cavalloro, V, Garbagnoli, M, Linciano, P, Rossi, D, Cavaletti, G, Costa, G, Alcaro, S, Miloso, M, Collina, S, Listro, Roberta, Malacrida, Alessio, Ambrosio, Francesca Alessandra, Rossino, Giacomo, Di Giacomo, Marcello, Cavalloro, Valeria, Garbagnoli, Martina, Linciano, Pasquale, Rossi, Daniela, Cavaletti, Guido, Costa, Giosuè, Alcaro, Stefano, Miloso, Mariarosaria, Collina, Simona, Listro, R, Malacrida, A, Ambrosio, F, Rossino, G, Di Giacomo, M, Cavalloro, V, Garbagnoli, M, Linciano, P, Rossi, D, Cavaletti, G, Costa, G, Alcaro, S, Miloso, M, Collina, S, Listro, Roberta, Malacrida, Alessio, Ambrosio, Francesca Alessandra, Rossino, Giacomo, Di Giacomo, Marcello, Cavalloro, Valeria, Garbagnoli, Martina, Linciano, Pasquale, Rossi, Daniela, Cavaletti, Guido, Costa, Giosuè, Alcaro, Stefano, Miloso, Mariarosaria, and Collina, Simona
- Abstract
The insurgence of drug resistance in treating Multiple Myeloma (MM) still represents a major hamper in finding effective treatments, although over the past decades new classes of drugs, such as proteasome inhibitors and immunomodulatory drugs, have been discovered. Recently, our research team, within a Nature-Aided Drug Discovery project, isolated from Hibiscus Sabdariffa L. calyces the secondary metabolite called Hib-ester which possesses antiproliferative properties against human multiple myeloma RPMI 8226 cells, reduces migration and cell invasion and inhibits proteasome without neurotoxic effects. In the present study, we explored the chemical spaces of the hit compound Hib-ester. We explored the structure-activity relationships (SAR), and we optimized the scaffold through sequentially modifying Hib-ester subunits. Compound screening was performed based on cytotoxicity against the RPMI 8226 cells to assess the potential efficacy toward human MM. The ability of the most effective molecules to inhibit the proteasome was evaluated and the binding mode of the most promising compounds in the proteasome chymotrypsin binding pocket was deciphered through molecular modeling simulations. Compounds 13 and 14 are more potent than Hib-ester, demonstrating that our strategy was suitable for the identification of a novel chemotype for developing possible drug candidates and hopefully widening the drug armamentarium against MM.
- Published
- 2022
6. Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair
- Author
-
Malacrida, Alessio, primary, Cavaletti, Guido, additional, and Miloso, Mariarosaria, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa—Part 2
- Author
-
Malacrida, Alessio, primary, Cavalloro, Valeria, additional, Martino, Emanuela, additional, Costa, Giosuè, additional, Ambrosio, Francesca Alessandra, additional, Alcaro, Stefano, additional, Rigolio, Roberta, additional, Cassetti, Arianna, additional, Miloso, Mariarosaria, additional, and Collina, Simona, additional
- Published
- 2021
- Full Text
- View/download PDF
8. Innovative 3D proteome-wide scale identification of ALKBH5 target for MV1035 small molecule able to reduce migration and invasiveness in U87 glioblastoma cell lines by SPILLO-PBSS
- Author
-
Malacrida, Alessio, primary, Rivara, Mirko, additional, Mariem, Omar Ben, additional, Di Domizio, Alessandro, additional, Cislaghi, Giacomo, additional, Miloso, Mariarosaria, additional, Zuliani, Valentina, additional, and Nicolini, Gabriella, additional
- Published
- 2021
- Full Text
- View/download PDF
9. Role of MAPKs in platinum-induced neuronal apoptosis
- Author
-
Scuteri, Arianna, Galimberti, Alessia, Maggioni, Daniele, Ravasi, Maddalena, Pasini, Silvia, Nicolini, Gabriella, Bossi, Mario, Miloso, Mariarosaria, Cavaletti, Guido, and Tredici, Giovanni
- Published
- 2009
- Full Text
- View/download PDF
10. In Vitro Evaluation of Rigosertib Antitumoral and Radiosensitizing Effects against Human Cholangiocarcinoma Cells
- Author
-
Malacrida, Alessio, primary, Rigolio, Roberta, additional, Celio, Luigi, additional, Damian, Silvia, additional, Cavaletti, Guido, additional, Mazzaferro, Vincenzo, additional, and Miloso, Mariarosaria, additional
- Published
- 2021
- Full Text
- View/download PDF
11. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells
- Author
-
Foudah, Dana, Redaelli, Serena, Donzelli, Elisabetta, Bentivegna, Angela, Miloso, Mariarosaria, Dalprà, Leda, and Tredici, Giovanni
- Published
- 2009
- Full Text
- View/download PDF
12. Breakthroughs in medicinal chemistry: new targets and mechanisms, new drugs, new hopes-7
- Author
-
Gütschow, Michael, Eynde, Jean Jacques Vanden, Jampilek, Josef, Kang, CongBao, Mangoni, Arduino, Fossa, Paola, Karaman, Rafik, Trabocchi, Andrea, Scott, Peter, Reynisson, Jóhannes, Rapposelli, Simona, Galdiero, Stefania, Winum, Jean-Yves, Brullo, Chiara, Prokai-Tatrai, Katalin, Sharma, Arun, Schapira, Matthieu, Azuma, Yasu-Taka, Cerchia, Laura, Spetea, Mariana, Torri, Giangiacomo, Collina, Simona, Geronikaki, Athina, García-Sosa, Alfonso, Vasconcelos, M Helena, Sousa, Maria Emília, Kosalec, Ivan, Tuccinardi, Tiziano, Duarte, Iola, Salvador, Jorge, Bertinaria, Massimo, Pellecchia, Maurizio, Amato, Jussara, Rastelli, Giulio, Gomes, Paula, Guedes, Rita, Sabatier, Jean-Marc, Estévez-Braun, Ana, Pagano, Bruno, Mangani, Stefano, Ragno, Rino, Kokotos, George, Brindisi, Margherita, González, Florenci, Borges, Fernanda, Miloso, Mariarosaria, Rautio, Jarkko, Muñoz-Torrero, Diego, Vanden Eynde, Jean Jacques, Vasconcelos, M. Helena, Gutschow, M., Eynde, J. J. V., Jampilek, J., Kang, C., Mangoni, A. A., Fossa, P., Karaman, R., Trabocchi, A., Scott, P. J. H., Reynisson, J., Rapposelli, S., Galdiero, S., Winum, J. -Y., Brullo, C., Prokai-Tatrai, K., Sharma, A. K., Schapira, M., Azuma, Y. -T., Cerchia, L., Spete, M., Torri, G., Collina, S., Geronikaki, A., Garcia-Sosa, A. T., Helena Vasconcelos, M., Sousa, M. E., Kosalec, I., Tuccinardi, T., Duarte, I. F., Salvador, J. A. R., Bertinaria, M., Pellecchia, M., Amato, J., Rastelli, G., Gomes, P. A. C., Guedes, R. C., Sabatier, J. -M., Estevez-Braun, A., Pagano, B., Mangani, S., Ragno, R., Kokotos, G., Brindisi, M., Gonzalez, F. V., Borges, F., Miloso, M., Rautio, J., Munoz-Torrero, D., Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Gutschow, M, Eynde, J, Jampilek, J, Kang, C, Mangoni, A, Fossa, P, Karaman, R, Trabocchi, A, Scott, P, Reynisson, J, Rapposelli, S, Galdier, S, Winum, J, Brullo, C, Prokai-Tatrai, K, Sharma, A, Schapira, M, Azuma, Y, Cerchia, L, Spete, M, Torri, G, Collina, S, Geronikaki, A, Garcia-Sosa, A, Helena Vasconcelos, M, Sousa, M, Kosalec, I, Tuccinardi, T, Duarte, I, Salvador, J, Bertinaria, M, Pellecchia, M, Amato, J, Rastelli, G, Gomes, P, Guedes, R, Sabatier, J, Estevez-Braun, A, Pagano, B, Mangani, S, Ragno, R, Kokotos, G, Brindisi, M, Gonzalez, F, Borges, F, Miloso, M, Rautio, J, and Munoz-Torrero, D
- Subjects
RM ,Pharmaceutical research ,molecular targeted therapy ,Chemistry, Pharmaceutical ,MESH: Pharmaceutical Preparations ,[SDV]Life Sciences [q-bio] ,Pharmaceutical Science ,animals ,chemistry, pharmaceutical ,drug discovery ,humans ,pharmaceutical preparations ,structure-activity relationship ,Q1 ,chemistry ,01 natural sciences ,Clinical chemistry ,Analytical Chemistry ,lcsh:QD241-441 ,03 medical and health sciences ,MESH: Chemistry, Pharmaceutical ,Química clínica ,MESH: Structure-Activity Relationship ,lcsh:Organic chemistry ,MESH: Drug Discovery ,CHIM/06 - CHIMICA ORGANICA ,MESH: Molecular Targeted Therapy ,pharmaceutical ,MESH: Animals ,RM695 ,Investigació farmacèutica ,Physical and Theoretical Chemistry ,030304 developmental biology ,0303 health sciences ,MESH: Humans ,010405 organic chemistry ,Medicinal Chemistry, New Targets, New Mechanisms, New Drugs ,Organic Chemistry ,R735 ,R1 ,3. Good health ,0104 chemical sciences ,Editorial ,n/a ,Chemistry (miscellaneous) ,Molecular Medicine ,Breakthroughs ,Medicinal Chemistry ,medicinal chemistry ,targets ,drugs ,molecules ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes is a series of editorials which is published on a biannual basis by the Editorial Board of the Medicinal Chemistry section of the journal Molecules. In these editorials, we highlight in brief reports (of about one hundred words) a number of recently published articles that describe crucial findings, such as the discovery of novel drug targets and mechanisms of action or novel classes of drugs, which may inspire future medicinal chemistry endeavors devoted to addressing prime unmet medical needs.
- Published
- 2020
13. Neurotoxicity of Platinum Compounds: Comparison of the Effects of Cisplatin and Oxaliplatin on the Human Neuroblastoma Cell Line SH-SY5Y
- Author
-
Donzelli, Elisabetta, Carfì, Maria, Miloso, Mariarosaria, Strada, Alberto, Galbiati, Stefania, Bayssas, Martine, Griffon-Etienne, Genevieve, Cavaletti, Guido, Grazia Petruccioli, Maria, and Tredici, Giovanni
- Published
- 2004
- Full Text
- View/download PDF
14. ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation
- Author
-
Donzelli, Elisabetta, Lucchini, Caterina, Ballarini, Elisa, Scuteri, Arianna, Carini, Fabrizio, Tredici, Giovanni, and Miloso, Mariarosaria
- Published
- 2011
- Full Text
- View/download PDF
15. Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
- Author
-
Listro, Roberta, primary, Stotani, Silvia, additional, Rossino, Giacomo, additional, Rui, Marta, additional, Malacrida, Alessio, additional, Cavaletti, Guido, additional, Cortesi, Michela, additional, Arienti, Chiara, additional, Tesei, Anna, additional, Rossi, Daniela, additional, Giacomo, Marcello Di, additional, Miloso, Mariarosaria, additional, and Collina, Simona, additional
- Published
- 2020
- Full Text
- View/download PDF
16. 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
- Author
-
Malacrida, Alessio, primary, Rivara, Mirko, additional, Di Domizio, Alessandro, additional, Cislaghi, Giacomo, additional, Miloso, Mariarosaria, additional, Zuliani, Valentina, additional, and Nicolini, Gabriella, additional
- Published
- 2020
- Full Text
- View/download PDF
17. Emerging role of mitogen-activated protein kinases in peripheral neuropathies
- Author
-
Cavaletti, Guido, Miloso, Mariarosaria, Nicolini, Gabriella, Scuteri, Arianna, and Tredici, Giovanni
- Published
- 2007
18. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated
- Author
-
BUCCELLATO, FRANCESCA R., MILOSO, MARIAROSARIA, BRAGA, MASSIMILIANO, NICOLINI, GABRIELLA, MORABITO, ALBERTO, PRAVETTONI, GIULIO, TREDICI, GIOVANNI, and SCALABRINO, GIUSEPPE
- Published
- 1999
19. Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa
- Author
-
Malacrida, Alessio, primary, Cavalloro, Valeria, additional, Martino, Emanuela, additional, Cassetti, Arianna, additional, Nicolini, Gabriella, additional, Rigolio, Roberta, additional, Cavaletti, Guido, additional, Mannucci, Barbara, additional, Vasile, Francesca, additional, Giacomo, Marcello Di, additional, Collina, Simona, additional, and Miloso, Mariarosaria, additional
- Published
- 2019
- Full Text
- View/download PDF
20. Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
- Author
-
Tesei, Anna, primary, Cortesi, Michela, additional, Pignatta, Sara, additional, Arienti, Chiara, additional, Dondio, Giulio Massimo, additional, Bigogno, Chiara, additional, Malacrida, Alessio, additional, Miloso, Mariarosaria, additional, Meregalli, Cristina, additional, Chiorazzi, Alessia, additional, Carozzi, Valentina, additional, Cavaletti, Guido, additional, Rui, Marta, additional, Marra, Annamaria, additional, Rossi, Daniela, additional, and Collina, Simona, additional
- Published
- 2019
- Full Text
- View/download PDF
21. Rigosertib as a radio-sensitizer for concurrent chemo-radiation treatment of cholangiocarcinoma (CCA): a comparative study in vitro
- Author
-
Malacrida, Alessio, Damian, Silvia, Celio, Luigi, Mazzaferro, Vincenzo, and Miloso, Mariarosaria
- Subjects
Cholangiocarcinoma ,Rigosertib ,radio-sensitizer ,antitumoral effects - Abstract
Cholangiocarcinoma (CCA) remains a therapeutic challenge. The small-molecule Rigosertib can selectively synchronize cancer cells to G2/M phase improving the efficacy of radiation. In our study, we evaluated in vitro Rigosertib (gifted by Onconova Therapeutics Inc) effects on two human CCA cell lines: EGI-1 and TFK-1. Rigosertib was compared with Gemcitabine (GEM) and 5-Fluorouracil (5-FU), two antineoplastic and radio-sensitizer agents used in the treatment of CCA. Rigosertib impaired cell viability (evaluated by Tripan-blue vital count) in both cell lines in a dose- and time-dependent manner (IC50 of 100nM at 24h). GEM and 5-FU had a IC50 of 30µM and 7µM after 24h, respectively. Cell migration and invasion tests was performed by scratch wound healing and Boyden chamber assay respectively. Rigosertib caused a 50% inhibition of the EGI-1 cell migration (10µM) and invasion (100nM), while the inhibitory effects on TFK-1 cells were observed with doses of 100µM and 10µM, respectively. GEM 30µM and 5-FU 7µM had no effect on cell migration and invasion. Evaluation of cell cycle by FACS cytometry showed a G2/M arrest in both cell lines after Rigosertib 100nM for 24h. Radio-sensitizing test was performed by clonogenic survival assay after irradiation. 24h Rigosertib pre-treatment (100nM for EG-1 and 1 µM for TFK-1) when followed by 2, 4 or 6 Gy irradiation, reduced survival in both CAA cell lines when compared with radiation alone. The Rigosertib radio-sensitizer effect was similar to that seen after GEM or 5-FU 24 pre-treatment both plus irradiation. However, 48h Rigosertib pre-treatment was more effective than radiation alone as well as GEM for 48h. Our study highlights the preliminary but promising preclinical activity of Rigosertib both as antitumoral and as a radio-sensitizer agent in CCA and provides a background for further investigations., Italian Journal of Anatomy and Embryology, Vol. 122, No. 1 (Supplement) 2017
- Published
- 2017
- Full Text
- View/download PDF
22. Antitumoral effects of Hibiscus Sabdariffa on human breast cancer cells
- Author
-
Erriquez, Jacopo, Malacrida, Alessio, Rodriguez Menendez, Virginia, Nicolini, Gabriella, and Miloso, Mariarosaria
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Hibiscus sabdariffa ,human breast cancer cells - Abstract
Hibiscus Sabdariffa (HS) is a plant commonly used in folk medicine (1). In recent years HS has gained great interest due to its important antioxidant, anti-inflammatory and antitumoral properties. In our work, we evaluated the in vitro anticancer effects of HS extract against two different human breast cancer cell lines: estrogen receptor (ER) positive MCF-7 cells and ER negative MDA-MB-231 cells. We tested both total extract (HSE) and one fraction obtained by ethyl acetate extraction (HSEC). MTT assay and Trypan Blue vital count showed a dose and time dependent reduction of the viability in both cell lines treated with different concentrations of HSE or HSEC compared to untreated control cells. A significantly marked reduction was observed in MCF-7 cells treated with HSEC. On the basis of our results we used the concentrations of 7.5mg/ml and 3.5mg/ml respectively for HSE and HSEC. In order to evaluate ER involvement in HS effect, we analyzed the cellular localization of the receptor (ERα isotype) by immunofluorescence experiments. Untreated MDA-MB-231 cells showed a low expression of the receptor mostly localized at the cytoplasmic level and treatment with HSE or HSEC didn’t change this state. Untreated MCF-7 cells showed a greater expression of the receptor, with nuclear and cytoplasmic localization. Following HSE or HSEC treatment ERα localization became more cytoplasmic and this effect was more evident after HSEC induction. These data were also confirmed by ERα western blot analysis. Subsequently, we studied HSE and HSEC ability to alter migration and invasion capacity of ER positive MCF-7 cells. Using a scratch wound healing assay we did not observe any change in the migration of cells compared to untreated cells. On the contrary, in a Boyden chamber invasion assay, HSE, and especially HSEC, induced reduction of MCF-7 cell invasion. In conclusion, we have demonstrated that HS is able to reduce cell viability of ER positive MCF-7 and ER negative MDA-MB-231 cells. This effect is more evident in MCF-7 cells in which ER localization and reduced cell invasion were observed. These results are more evident after HSEC treatment. Further studies will be needed to better elucidate the involved mechanisms of action., Italian Journal of Anatomy and Embryology, Vol. 121, No. 1 (Supplement) 2016
- Published
- 2017
- Full Text
- View/download PDF
23. Expression of neural markers by undifferentiated rat mesenchymal stem cells
- Author
-
Foudah, Dana, Redondo, Juliana, Caldara, Cristina, Carini, Fabrizio, Tredici, Giovanni, and Miloso, Mariarosaria
- Subjects
Intermediate filament proteins ,Nervous system diseases ,Stem cells ,Biotechnology industry ,High technology industry - Abstract
The spontaneous expression of neural markers by mesenchymal stem cells (MSCs) has been considered to be a demonstration of MSCs' predisposition to differentiate towards neural lineages. In view of their application in cell therapy for neurodegenerative diseases, it is very important to deepen the knowledge about this distinctive biological property of MSCs. In this study, we evaluated the expression of neuronal and glial markers in undifferentiated rat MSCs (rMSCs) at different culture passages (from early to late). rMSCs spontaneously expressed neural markers depending on culture passage, and they were coexpressed or not with the neural progenitor marker nestin. In contrast, the number of rMSCs expressing mesengenic differentiation markers was very low or even completely absent. Moreover, rMSCs at late culture passages were not senescent cells and maintained the MSC immunophenotype. However, their differentiation capabilities were altered. In conclusion, our results support the concept of MSCs as multidifferentiated cells and suggest the existence of immature and mature neurally fated rMSC subpopulations. A possible correlation between specific MSC subpopulations and specific neural lineages could optimize the use of MSCs in cell transplantation therapy for the treatment of neurological diseases., 1. Introduction Cellular therapies using mesenchymal stem cells (MSCs) represent a promising approach in regenerative medicine, tissue-engineering, and autoimmune disease treatment. Clinical studies have confirmed the therapeutic potential of MSCs [...]
- Published
- 2012
- Full Text
- View/download PDF
24. EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS
- Author
-
Malacrida, A, MILOSO, MARIAROSARIA, MALACRIDA, ALESSIO, Malacrida, A, MILOSO, MARIAROSARIA, and MALACRIDA, ALESSIO
- Abstract
Hibiscus Sabdariffa (HS) is a plant of the Malvacee family commonly cultured in tropical and subtropical countries. It is mainly known as the main ingredient for the preparation of cold drink called Karkadè. Calices and leaves of HS plant are also used in folk medicine thanks to their antioxidant and anti-inflammatory properties. In recent years, HS has also gained great interest as a possible antitumoral agent. In the present PhD project, we evaluated the antitumoral effects of HS against multiple mye-loma cells in vitro. Multiple myeloma is the most frequent hematological malignancy world-wide. In recent years, new drugs have increased the survival expectancy of patients. Despite this, new therapeutic approaches are necessary, especially for high multiple myeloma hetero-geneity and for relapsed or refractory multiple myeloma. The project was organized in three distinct phases: 1- Evaluation of antitumoral effects of HS against RPMI 8226 human multiple myeloma cells. We demonstrated by MTT and Trypan blue assays that a total HS extract (HSE) and one of its fraction obtained by liquid-liquid extraction (HSEC) were able to impair cell viability of human multiple myeloma RPMI 8226 in a dose and time dependent manner. HSE cell viability reduction was due to a cytostatic action, while HSEC was more cytotoxic and induced a caspase dependent apoptosis. Moreover, both HSE and HSEC impaired cell migration and invasion of RPMI 8226 cells in a Boyden chamber as-say. We also demonstrated in in vitro model of neurotoxicity (dorsal root ganglia model) that HSE and HSEC concentrations used in our experiments were not neurotoxic. In RPMI 8226 cells autophagy and proteasome activity were impaired by both HSE and HSEC. MAPK p38 activation was observed in the first 6h of treatment, while ERK 1 and ERK 2 activation occurred between 16 and 48h. 2- Evaluation of combinations between Bortezomib (BTZ) and HSE or HSEC against RPMI 8226 multiple myeloma cells. We evaluated several combinat, Hibiscus Sabdariffa (HS) is a plant of the Malvacee family commonly cultured in tropical and subtropical countries. It is mainly known as the main ingredient for the preparation of cold drink called Karkadè. Calices and leaves of HS plant are also used in folk medicine thanks to their antioxidant and anti-inflammatory properties. In recent years, HS has also gained great interest as a possible antitumoral agent. In the present PhD project, we evaluated the antitumoral effects of HS against multiple mye-loma cells in vitro. Multiple myeloma is the most frequent hematological malignancy world-wide. In recent years, new drugs have increased the survival expectancy of patients. Despite this, new therapeutic approaches are necessary, especially for high multiple myeloma hetero-geneity and for relapsed or refractory multiple myeloma. The project was organized in three distinct phases: 1- Evaluation of antitumoral effects of HS against RPMI 8226 human multiple myeloma cells. We demonstrated by MTT and Trypan blue assays that a total HS extract (HSE) and one of its fraction obtained by liquid-liquid extraction (HSEC) were able to impair cell viability of human multiple myeloma RPMI 8226 in a dose and time dependent manner. HSE cell viability reduction was due to a cytostatic action, while HSEC was more cytotoxic and induced a caspase dependent apoptosis. Moreover, both HSE and HSEC impaired cell migration and invasion of RPMI 8226 cells in a Boyden chamber as-say. We also demonstrated in in vitro model of neurotoxicity (dorsal root ganglia model) that HSE and HSEC concentrations used in our experiments were not neurotoxic. In RPMI 8226 cells autophagy and proteasome activity were impaired by both HSE and HSEC. MAPK p38 activation was observed in the first 6h of treatment, while ERK 1 and ERK 2 activation occurred between 16 and 48h. 2- Evaluation of combinations between Bortezomib (BTZ) and HSE or HSEC against RPMI 8226 multiple myeloma cells. We evaluated several combinat
- Published
- 2017
25. Human Mesenchymal Stem Cells and Endothelial Progenitor Cells exert a neuroprotective effect on rat cortical neurons injured by oxygen and glucose deprivation
- Author
-
Donzelli, Elisabetta, Nicolini, Gabriella, Scuteri, Arianna, De Cristofaro, Valentina, Rigolio, Roberta, Ceresa, Cecilia, and Miloso, Mariarosaria
- Subjects
nervous system ,Mesenchymal stem cells ,endothelial progenitor cells: oxygen and glucose deprivation ,embryonic cortical neurons - Abstract
Oxygen and glucose deprivation (OGD) due to ischemic events or trauma in the brain result in neuronal loss. The therapeutic approaches available inadequate and often the outcome is unfavorable for the patient or at least unpredictable. Stem cells could be useful for the treatment of OGD injured-neurons. Mesenchymal Stem Cells (MSCs), isolated from bone marrow as well as from various tissues, have poor immunogenicity and neuroprotective properties being able to alleviate ischemic brain injuries in animal models. The Endothelial Progenitor Cells (EPCs) are present at low frequencies both in the bone marrow and in the peripheral blood. They are thought to play a role in the recovery of cerebrovasculature integrity after stroke. In the present study we evaluated the potential neuroprotective effect of human MSCs and human EPCs on rat embryonic cortical neurons injured by OGD. OGD was induced by incubating the cortical neurons in a hypoxia chamber in a 95% N2 + 5% CO2 atmosphere at 37°C without glucose. To set up the experimental protocol, OGD was maintained for 1, 2 and 3 hours. The neurons were returned in normoxic atmosphere and after 2 and 5 days neuronal survival was evaluated by MTT assay, LDH assay and viable cellular counting. The 2 hours OGD was able to reduce neuronal viability by 50% and was chosen for the subsequent experiments. To assess MSCs and EPCs neuroprotective action, after 2 hours-long OGD the neurons were 1) co-cultured with either MSCs or EPCs seeded on a cell culture insert avoiding direct contact while sharing the same medium, or 2) cultured in a medium previously conditioned by either MSCs or EPCs. Neuronal survival was evaluated by MTT assay after 2 and 5 days. Both MSCs and EPCs increased neuronal survival after ODG. The effect was observed in absence of a direct contact between MSCs or EPCs and the injured neurons, suggesting that the release of soluble factors may be involved in their neuroprotective action. In conclusion both MSCs and EPCs could represent a potential therapeutic approach for the treatment of brain ischemic injury. Further studies are needed to identify the specific molecules and pathways that play a role in the neuroprotective effect of MSCs and EPCs., Italian Journal of Anatomy and Embryology, Vol. 120, No. 1 (Supplement) 2015
- Published
- 2015
- Full Text
- View/download PDF
26. The effect of culture on human bone marrow mesenchymal stem cells: Focus on DNA methylation profiles
- Author
-
Bentivegna, A, Roversi, G, Riva, G, Paoletta, L, Redaelli, S, Miloso, M, Tredici, G, Dalpra', L, BENTIVEGNA, ANGELA, ROVERSI, GAIA, RIVA, GABRIELE, REDAELLI, SERENA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, DALPRA', LEDA, Bentivegna, A, Roversi, G, Riva, G, Paoletta, L, Redaelli, S, Miloso, M, Tredici, G, Dalpra', L, BENTIVEGNA, ANGELA, ROVERSI, GAIA, RIVA, GABRIELE, REDAELLI, SERENA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, and DALPRA', LEDA
- Abstract
Human bone marrow mesenchymal stem cells (hBM-MSCs) are the best characterized multipotent adult stem cells. Their self-renewal capacity, multilineage differentiation potential, and immunomodulatory properties have indicated that they can be used in many clinical therapies. In a previous work we studied the DNA methylation levels of hBM-MSC genomic DNA in order to delineate a kind of methylation signature specific for early and late passages of culture. In the present work we focused on the modification of the methylation profiles of the X chromosome and imprinted loci, as sites expected to be more stable than whole genome. We propose a model where cultured hBM-MSCs undergo random modifications at the methylation level of most CGIs, nevertheless reflecting the original methylation status. We also pointed out global genome-wide demethylation connected to the long-term culture and senescence. Modification at CGIs promoters of specific genes could be related to the decrease in adipogenic differentiation potential. In conclusion, we showed important changes in CGIs methylation due to long-term in vitro culture that may affect the differentiation potential of hBM-MSCs. Therefore it is necessary to optimize the experimental conditions for in vitro expansion in order to minimize these epigenetic changes and to standardize safer procedures.
- Published
- 2016
27. Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells
- Author
-
Malacrida, A, Maggioni, D, Cassetti, A, Nicolini, G, Cavaletti, G, Miloso, M, MALACRIDA, ALESSIO, MAGGIONI, DANIELE, NICOLINI, GABRIELLA, CAVALETTI, GUIDO ANGELO, MILOSO, MARIAROSARIA, Malacrida, A, Maggioni, D, Cassetti, A, Nicolini, G, Cavaletti, G, Miloso, M, MALACRIDA, ALESSIO, MAGGIONI, DANIELE, NICOLINI, GABRIELLA, CAVALETTI, GUIDO ANGELO, and MILOSO, MARIAROSARIA
- Abstract
Cancer is a leading cause of death worldwide. Despite therapeutic improvements, some cancers are still untreatable. Recently there has been an increasing interest in the use of natural substances for cancer prevention and treatment. Hibiscus sabdariffa (HS) is a plant, belonging to Malvaceae family, widespread in South Asia and Central Africa. HS extract (HSE) used in folk medicine, gained researchers' interest thanks to its antioxidant, anti-inflammatory, and chemopreventive properties. In the present study, we initially assessed HSE effect on a panel of human tumor cell lines. Then we focused our study on the following that are most sensitive to HSE action cell lines: Multiple Myeloma (MM) cells (RPMI 8226) and Oral Squamous Cell Carcinoma (OSCC) cells (SCC-25). In both RPMI 8226 and SCC-25 cells, HSE impaired cell growth, exerted a reversible cytostatic effect, and reduced cell motility and invasiveness. We evaluated the involvement of MAPKs ERK1/2 and p38 in HSE effects by using specific inhibitors, U0126 and SB203580, respectively. For both SCC-25 and RPMI 8226, HSE cytostatic effect depends on p38 activation, whereas ERK1/2 modulation is crucial for cell motility and invasiveness. Our results suggest that HSE may be a potential therapeutic agent against MM and OSCC.
- Published
- 2016
28. Antitumoral effects of Hibiscus sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells
- Author
-
MILOSO, MARIAROSARIA, MAGGIONI, DANIELE, MALACRIDA, ALESSIO, FOUDAH, DANA, CALDARA, CRISTINA, TREDICI, GIOVANNI, NICOLINI, GABRIELLA, Miloso, M, Maggioni, D, Malacrida, A, Foudah, D, Caldara, C, Tredici, G, and Nicolini, G
- Subjects
BIO/16 - ANATOMIA UMANA ,Hibiscus sabdarifa, human multiple myeloma cells, human oral squamous cell carcinoma cells, ERKs, PI3-K ,Hibiscus sabdarifa ,human multiple myeloma cells ,human oral squamous cell carcinoma cells ,ERKs ,PI3-K - Abstract
Epidemiological data consistently demonstrate a reduced cancer risk associated with a polyphenols rich diet. Hibiscus sabdarifa (HS), a polyphenols rich plant widely consumed worldwide as beverage and used in folk medicine, has recently gained interest thanks to its antioxidant, anti-inflammatory and chemopreventive properties. In the present study we investigated the antitumoral potential of HS extract in two different human tumor cell lines: Multiple Myeloma cells (RPMI 8226) and Oral Squamous Cell Carcinoma cells (SCC-25). MTT assays showed that HS extract induced a dose-dependent viability reduction in both the cells lines. For the subsequent experiments we used HS at the concentration of 5 mg/ml that was the most effective in inducing cell viability reduction after 48h of treatment. Viable cell count using trypan blue staining demonstrated that the HS extract induced decrease in cell growth of both the cell lines and this was due to a reversible cytostatic rather than a cytotoxic effect. Wound-healing and cell invasion assays, respectively performed by a scratch of cell monolayer and Boyden Chamber transwell test, demonstrated that HS extract was able to reduce motility and invasiveness in both RPMI 8226 and SCC-25 cells. The chemical inhibition of ERK1/ERK2 and PI3K, with U0126 and wortmannin respectively, reduces proliferation and migration of both SSC-25 and RPMI cells and HB extract treatment played an additive action with the inhibitors. In conclusion, our results suggest that HS extract have antitumoral properties, since it proved to inhibit tumoral cell growth and cell migration and invasiveness. It is interesting to note that HS extract is effective against two very different tumor cell lines. In fact, RPMI 8226 cells are of hematopoietic origin and grow in suspension, whereas SCC-25 cells derive from epithelium and are characterized by adherent cell growth. Therefore, although further studies are needed to clarify the molecular mechanisms involved in its action, we proposed HS as a potential chemopreventive agent., Italian Journal of Anatomy and Embryology, Vol 118, No 2 (Supplement) 2013
- Published
- 2014
- Full Text
- View/download PDF
29. Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1
- Author
-
Rigolio, Roberta, Cadamuro, Massimiliano, Caramia, Grazia, Malacrida, Alessio, Maggioni, Daniele, Foudah, Dana, Miloso, Mariarosaria, Rigolio, R, Cadamuro, M, Caramia, G, Malacrida, A, Maggioni, D, Foudah, D, and Miloso, M
- Subjects
BIO/16 - ANATOMIA UMANA ,Cholangiocarcinoma, EGI-1 cells, Baicalin, cell viability, cell migration ,Cholangiocarcinoma ,EGI-1 cells ,Baicalin ,cell viability ,cell migration - Abstract
Cholangiocarcinoma (CCA) is the second most frequent primary liver neoplasia. It mainly arises from the malignant transformation of biliary epithelial cells, although it might originate from either hepatic progenitor cells at the Hering canals or transformed hepatocytes. CCA is a highly aggressive tumor with extremely poor prognosis and limited therapeutic approaches. Baicalin (BA) is one of the main bioactive flavonoids identified in the Scutellaria Baicalensis Georgi root dried extract which is extensively used in the Chinese traditional medicine. Together with the anti-inflammatory effect, the anti-neoplastic action is the most relevant BA property demonstrated on cancer cells of different origin. Being aware of the need of new therapeutic weapons for CCA treatment, we investigated whether Baicalin could exert anti-proliferative and anti-migratory effect on EGI-1 cells, a highly metastatic CCA cell line derived from bile duct carcinoma. We first tested different BA concentrations (from 5 to 200μM) in limiting EGI-1 viability using MTT assay. After 24h and 48h treatment, 5 and 10μM BA had no effect while rising from 25μM to 200μM (i.e. 25, 50, 100 and 200μM) BA exerted a significant cell viability reduction already at 24h and increased after 48h BA exposure. This reduction well correlated with the adherent absolute cell number decrease and it cannot be due to BA induced cell cycle impairment after neither 24 nor 48h treatment. We also evaluated the anti-migratory BA potential by a wound healing assay adding different BA concentrations (5, 25, 50,100 and 200μM) to the culture medium immediately after performing a wound on confluent cell cultures. All BA concentrations but 5μM induced a significant reduction in the EGI-1 migration rate after 24h treatment. Moreover 25, 50 and 10μM BA showed similar migration inhibition extent at 24 and 48h whilst 200μM BA exerted a stronger inhibitory effect already after 24h exposure which increased with time in a significant way. Taken together our preliminary results demonstrate that BA impairs CCA cell viability and migration suggesting a promising adjuvant therapeutic use for BA as antitumoral agent., Italian Journal of Anatomy and Embryology, Vol 119, No 1 (Supplement) 2014
- Published
- 2014
30. Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells
- Author
-
Malacrida, Alessio, primary, Maggioni, Daniele, additional, Cassetti, Arianna, additional, Nicolini, Gabriella, additional, Cavaletti, Guido, additional, and Miloso, Mariarosaria, additional
- Published
- 2016
- Full Text
- View/download PDF
31. The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles
- Author
-
Bentivegna, Angela, primary, Roversi, Gaia, additional, Riva, Gabriele, additional, Paoletta, Laura, additional, Redaelli, Serena, additional, Miloso, Mariarosaria, additional, Tredici, Giovanni, additional, and Dalprà, Leda, additional
- Published
- 2016
- Full Text
- View/download PDF
32. Human Mesenchymal Stem Cells Protect Dorsal Root Ganglia from the Neurotoxic Effect of Cisplatin
- Author
-
Scuteri, A, Ravasi, M, Monfrini, M, Milano, A, D'Amico, G, Miloso, M, Tredici, G, SCUTERI, ARIANNA, RAVASI, MADDALENA, MONFRINI, MARIANNA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, Scuteri, A, Ravasi, M, Monfrini, M, Milano, A, D'Amico, G, Miloso, M, Tredici, G, SCUTERI, ARIANNA, RAVASI, MADDALENA, MONFRINI, MARIANNA, MILOSO, MARIAROSARIA, and TREDICI, GIOVANNI
- Abstract
Background/Aim: Peripheral neurotoxicity is a dose-limiting factor of many chemotherapeutic agents, including cisplatin. Mesenchymal stem cells are promising for the treatment of several neurological disorders, and our aim was to verify the neuroprotective potential of human mesenchymal stem cells (hMSCs) on dorsal root ganglia (DRG) exposed to cisplatin. Materials and Methods: DRG were exposed to different cisplatin concentrations and then co-cultured with hMSCs or with hMSC-conditioned medium. Results: hMSCs showed a neuroprotective effect on cisplatininduced death of DRG, mediated by direct contact. Moreover, DRG exhibited an MSC-dependent promotion of neurite outgrowth, in particular at early time points. For this effect, the expression of Neurite Outgrowth Inhibitor (NOGO) and Myelin Associated Glycoprotein (MAG) by hMSCs was pivotal. Conclusion: hMSCs are a promising tool for reducing the neurotoxic effect of cisplatin.
- Published
- 2015
33. Embryonic rat dorsal root ganglia organotypic culture: a morphometric model to test neurotoxicology
- Author
-
Nicolini, Gabriella, Miloso, Mariarosaria, Maggioni, Daniele, Nobbio, Lucilla, and Tredici, Giovanni
- Subjects
Neurotoxicity ,in vitro model ,dorsal root ganglia ,morphometric analysis - Abstract
Neurotoxicity is a common dose-limiting side-effect of several drugs (Cavaletti et al., 2008). So far a validated test method to screen drugs neurotoxicity does not exist, therefore in this interdepartment study we have analyzed the effectiveness of a morphometric neurotoxicty assessment model. Drug neurotoxicity evaluation is based on embryonic rat dorsal root ganglia (DRG) organotypic culture. DRG primary sensory neurons are the principal target of drugs neurotoxic action. In fact, primary sensory neurons lie outside the blood-nerve barrier and are supplied by capillaries with fenestrated walls. Moreover, the axons of these cells are among the longest of the entire nervous system and, therefore, are more susceptible to any agent that interferes with the energy metabolism or the structural basis of axonal transport. In particular, in this interdepartment study, the interference of the under study neurotoxic compound with NGF-induced neurite elongation is analysed. The effectiveness and reproducibility of this model, even if commonly used to test drugs, has not yet been demonstrated. In order to assess the validity of this in vitro model, antineoplastic drugs known to be in clinical use and in animal models neurotoxic (paclitaxel and oxaliplatin) or not dangerous (cyclophosphamide and 5-Fluorouracil) have been tested. DRGs explanted from E15 rat embryos have been treated for 24h with drugs concentrations comparable to those achievable in vivo. The length of the longest neurite of each DRG has been measured by ImageJ program. Experiments have been performed by three different blinded researchers in two different laboratories. Mean and standard deviation of each experiment were obtained, subsequently the mean value and standard deviation of the three independent experiments for each researcher were calculated. Data obtained by the three researchers in two different laboratories resulted statistically comparable and no significant differences were detected (One Way Anova analysis of variance and Tukey post test; p, Italian Journal of Anatomy and Embryology, Vol 117, No 2 (Supplement) 2012
- Published
- 2013
- Full Text
- View/download PDF
34. Evaluation of Valproic Acid, Valpromide and Hibiscus Sabdariffa effects on adipogenic and osteogenic differentiation of human Mesenchymal Stem Cells
- Author
-
CALDARA, CRISTINA, DONZELLI, ELISABETTA, FOUDAH, DANA, TREDICI, GIOVANNI, MILOSO, MARIAROSARIA, Caldara, C, Donzelli, E, Foudah, D, Tredici, G, and Miloso, M
- Subjects
BIO/16 - ANATOMIA UMANA ,Valproic Acid, Valpromide, Hibiscus Sabdariffa, adipogenic, osteogenic, meenchymal stem cells - Published
- 2013
35. Human oral squamous cell carcinoma proliferation and migration prevented by two flavonoids
- Author
-
Nicolini, Gabriella, Maggioni, Daniele, Biffi, Luisa, Ceresa, Cecilia, Scuteri, Arianna, Garavello, Werner, Miloso, Mariarosaria, Nicolini, G, Maggioni, D, Biffi, L, Ceresa, C, Scuteri, A, Garavello, W, and Miloso, M
- Subjects
stomatognathic diseases ,Naringenin ,Myricetin ,in vitro ,OSCC ,anticancer effect ,BIO/17 - ISTOLOGIA - Abstract
Oral Cancer (OC) is one of the most frequent cancer in Head and Neck district and Oral Squamous Cell Carcinoma (OSCC) constitutes the large majority of the neoplasia arising in oral cavity. OSCC remains a hampering matters for clinics, since the overall disease free survival has not significantly increased during the last decades and invasion to surrounding tissue and to regional lymph nodes is often reported. Therefore new strategies to prevent and inhibit OSCC growth and invasion are highly desirable and new therapeutic approaches are currently tempted also with the use of natural compounds. Myricetin (MYR) and Naringenin (NAR), two naturally occurring flavonoids, widely diffused in plants, fruits and vegetable, have recently gained consideration thanks to their anti oxidant, anti inflammatory and anti tumoral properties. In this study their potential anticancer effect has been evaluated on an OSCC cell line, SCC-25 and on spontaneously immortalized non tumoral keratinocytes, HaCaT cells. MYR and NAR induce a significant cell growth inhibition in SCC-25 cells, in addition NAR selectively affected cancer cells, since it does not impair HaCaT cell growth. Furthermore an additive effect of MYR and NAR has been highlighted. The cell proliferation inhibition is not related to apoptosis induction, as demonstrated by evaluation of phosphatidyl serine membrane translocation and dapi staining. On the contrary MYR and NAR effect depends on the cell cycle progression impairment. Wound-healing and cell invasion assays, respectively performed by cell monolayer scratch and Boyden Chamber transwell test, demonstrate that the two flavonoids are able to reduce motility and invasiveness on both SCC-25 and HaCaT cells. In conclusion the results of the present study show the anticancer potential of NAR and MYR on OSCC, since both flavonoids prevent cancer cell proliferation through a cytostatic effect, by the impairment of cell cycle progression. Moreover both the flavonoids inhibit cell migration, thus highlighting their potential effect as anti metastatic agents., Italian Journal of Anatomy and Embryology, Vol 118, No 2 (Supplement) 2013
- Published
- 2013
36. Human Mesenchymal Stem Cells protection on Cisplatin treated Dorsal Root Ganglia
- Author
-
RAVASI, MADDALENA, MAGGIONI, DANIELE, MONFRINI, MARIANNA, DONZELLI, ELISABETTA, FOUDAH, DANA, MILOSO, MARIAROSARIA, SCUTERI, ARIANNA, TREDICI, GIOVANNI, Milano, A, D’Amico, G, Ravasi, M, Maggioni, D, Milano, A, Monfrini, M, Donzelli, E, Foudah, D, D’Amico, G, Miloso, M, Scuteri, A, and Tredici, G
- Subjects
Mesenchymal Stem Cell ,peripheral neuropathy ,BIO/16 - ANATOMIA UMANA ,Cisplatin - Abstract
The induction of a peripheral neuropathy is a very common side effect of many chemotherapeutic agents, including platinum compounds, and it often represents the dose limiting factor for drug clinical use. Several strategies have been suggested to reduce drug neurotoxicity without affecting the antineoplastic potential, but up to now results were not encouraging. Recently, it has been demonstrated that Mesenchymal Stem Cells (MSCs) are able to promote the survival and the maturation of untreated sensory neurons of dorsal root ganglia (DRG), which represent also the target of drug neurotoxicity. Aim of this work is to verify the neuroprotective potential of MSCs on rat DRG exposed to cisplatin (CDDP), a chemotherapeutic and neurotoxic agent. DRG post-mitotic explants from E15 rat embryos were exposed for 24 hours to different cisplatin concentrations. After 24 hours, medium was changed and DRG were directly co-cultured with human MSCs (hMSCs) or with hMSCs conditioned medium (hMSC-CM). DRG explants were photographed every day up to 1 month, and the longest neurite of each DRG was measured to evaluate neurotoxicity. DRG survival was estimated by measuring the death area percentage. The survival of CDDP-treated DRG was increased after the co-cultures with hMSCs, and both hMSCs and hMSC-CM were able to improve the neurite outgrowth of untreated and CDDP-treated DRG after 48 hours. This MSC-dependent increase of neurite length was however no longer evident at later times (1 month). This effect on neurite elongation was probably mediated by CSPG, MAG and Nogo, some proteins involved in the modulation of neurite elongation, which resulted expressed and released in the culture medium of hMSCS. Our results demonstrated a neuroprotective effect of hMSCs on CDDP toxicity and evidenced the ability of these cells to modulate neurite elongation. In this way MSCs could represent a possible mean to limit the neurotoxicity on DRG which arises after cisplatin therapy.
- Published
- 2012
37. Adult human mesenchymal stem cells effect on cisplatin treated dorsal root ganglia survival and differentiation
- Author
-
RAVASI, MADDALENA, SCUTERI, ARIANNA, MONFRINI, MARIANNA, MAGGIONI, DANIELE, DONZELLI, ELISABETTA, FOUDAH, DANA, TREDICI, GIOVANNI, MILOSO, MARIAROSARIA, Milano, A, Ravasi, M, Scuteri, A, Milano, A, Monfrini, M, Maggioni, D, Donzelli, E, Foudah, D, Tredici, G, and Miloso, M
- Subjects
BIO/16 - ANATOMIA UMANA ,mesenchymal stem cells, cisplatin, dorsal root ganglia, survival, differentiation - Published
- 2012
38. Effects of valproic Acid, berberin and resveratrol on human mesenchymal stem cells adipogenic differentiation
- Author
-
Donzelli, Elisabetta, Nicolini, Gabriella, Caldara, Cristina, Scuteri, Arianna, Miloso, Mariarosaria, Donzelli, E, Nicolini, G, Caldara, C, Scuteri, A, and Miloso, M
- Subjects
valproic Acid, berberin, resveratrol, human mesenchymal stem cells, adipogenic differentiation ,BIO/16 - ANATOMIA UMANA ,valproic acid ,berberin ,resveratrol ,human mesenchymal stem cells ,adipogenic differentiation ,in vitro study - Abstract
Nowadays obesity and its related diseases represent a major health problem with an increasing worldwide prevalence. Hyperplasia and hypertrophy of adipocytes lead to an excessive fat accumulation that is not efficiently prevented by current pharmacological treatments. So the research on anti-obesity drugs with good efficacy and tolerability able both to prevent and to reduce fat accumulation is of pivotal interest. In the present study we evaluated in vitro the effects of Valproic Acid, Berberin and Resveratrol on adipogenesis. Our experimental model was represented by human Mesenchymal Stem Cells (hMSCs), physiological precursors of adipocytes that can differentiate into adipocytes also in vitro. Preliminary cytotoxicity assays were performed in order to choose non-toxic doses of the three drugs. hMSCs were induced to adipogenic differentiation and treated with Valproic Acid, Berberin and Resveratrol at the selected doses. Controls were represented by hMSCs treated for adipogenesis in absence of the drugs. At different time points intracellular lipid droplets accumulation, a typical feature of adipogenesis, was assessed by Oil Red O staining. Valproic Acid, Berberin and Resveratrol inhibited hMSCs adipogenic differentiation in a dose dependent manner as demonstrated by the reduction of the lipid droplets accumulation. To understand the molecular mechanisms of the drugs-induced adipogenesis inhibition, we focused our attention on the effects of the drugs treatment on cell cycle progression, known to be altered by many antiadipogenic drugs, and on the MAP Kinases ERK1 and ERK2, involved in the adipogenesis control. We evaluated the expression of cyclins and CDKs by immunoblotting and flow-cytometry analyses, demonstrating that Valproic Acid, Berberin and Resveratrol interfere on cell cycle progression. The expression and the phosphorylation status of the two kinases ERK1 and ERK2 were assessed by immunoblotting demonstrating an increase of ERK1 phosphorylation (i.e. activation) in hMSCs treated with Berberin and a reduction in hMSCs treated with Valproic Acid and Resveratrol compared to control cells. No changes in phosphorylation and expression of ERK2 were observed. Our study demonstrate that Valproic Acid, Berberin and Resveratrol exert an anti-adipogenic effect in our experimental model. The mechanisms of action of these drugs involve the alteration of cell cycle progression and, at least in part, ERK1/2 modulation. However other molecular pathways are likely implicated and other studies are required to identify them., Italian Journal of Anatomy and Embryology, Vol 116, No 1 (Supplement) 2011
- Published
- 2011
39. Evaluation of neural markers expression in human mesenchymal stem cells after mesengenic differentiation
- Author
-
Foudah, Dana, Scuteri, Arianna, Redondo, Juliana, Tredici, Giovanni, Miloso, Mariarosaria, Foudah, D, Scuteri, A, Redondo, J, Tredici, G, and Miloso, M
- Subjects
endocrine system ,mesengenic differentiation ,BIO/16 - ANATOMIA UMANA ,human mesenchymal stem cell ,equipment and supplies ,human mesenchymal stem cells ,neural markers ,neural marker - Abstract
Introduction. Mesenchymal Stem Cells (MSCs) are adult multipotent cells able to differentiate in mesengenic (osteogenic, adipogenic, condrogenic) and non mesengenic lineages (e.g. neural) under appropriate culture conditions. MSCs represent a very promising therapeutic approach in different settings particularly for tissue repair and regeneration. The knowledge of human MSCs (hMSCs) biological properties is very important to optimize their clinical application. In view of MSCs application in neurodegenerative diseases, the neuronal differentiation potential of hMSCs has been also explored. Our preliminary data demonstrated that the neuronal markers beta III tubulin and NeuN were spontaneously expressed by a high percentage of undifferentiated hMSCs independently from serum presence and number of culture passages. The expression of neural markers by MSCs in absence of any differentiative agents is considered as a demonstration of MSC neural predisposition. The aim of this work was to evaluate if these markers, known to be neuronal ones, continued to be expressed also in hMSCs differentiated towards mesengenic lineages. Methods. hMSCs were obtained after patient consensus, from iliac crest bone marrow. In according to the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy, the isolated hMSCs were plastic-adherent, capable of extensive proliferation when maintained in standard culture conditions, lacked of hematopoietic markers expression and presented specific surface antigens. hMSCs were differentiated toward osteogenic, adipogenic and chondrogenic lineages using specific in vitro protocols. The expression of the neuronal markers beta III tubulin and NeuN were evaluated by immunofluorescence experiments at different time points depending on the differentiation protocol used. hMSCs cultured in absence of any differentiative agent represented controls. Results. In our experiments the most of hMSCs differentiated in osteogenic and adipogenic lineages expressed the neuronal markers beta III tubulin and NeuN. Unlike, chondrogenic differentiated hMSCs didn’t express these markers. Conclusions. The finding that hMSCs differentiated into adipogenic and osteogenic lineages express neuronal markers such as beta III tubulin and NeuN raises doubts about the reliability of these markers as indicators of neuronal differentiation and suggests that their expression could be an intrinsic property of a wide range of cellular types. Further studies are necessary to understand the specific biological role of of beta III tubulin and NeuN in hMSCs differentiated towards mesengenic lineages., Italian Journal of Anatomy and Embryology, Vol 116, No 1 (Supplement) 2011
- Published
- 2011
40. MSCs reduce neuronal cell death in glutamate-treated cortical neurons
- Author
-
SCUTERI, ARIANNA, MAGGIONI, DANIELE, DONZELLI, ELISABETTA, RAVASI, MADDALENA, RODRIGUEZ MENENDEZ, VIRGINIA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, Scuteri, A, Maggioni, D, Donzelli, E, Ravasi, M, RODRIGUEZ MENENDEZ, V, Miloso, M, and Tredici, G
- Subjects
Glutammate ,BIO/16 - ANATOMIA UMANA ,Cortical neuron ,Mesenchymal STem Cells - Abstract
Multiple sclerosis (MS) is a chronic immuno-mediated inflammatory and demyelinating disease characterised by the presence of both demyelinating lesions and axonal degeneration, which lead to the reduction of nerve conduction velocity and the development of concomitant neurological deficits. Recently, Mesenchymal Stem Cells (MSCs) have been proposed in in vivo studies as promising therapeutic treatment for MS mainly for their capacity to modulate the immune response, moreover, during our previous experiments we found that rat undifferentiated MSC promote Dorsal Root Ganglia neurons survival and maturation. The aim of this study is to verify the potential protective effect of MSCs on an in vitro model of MS represented by rat primary cultures of cortical neurons. Since glutamate excitotoxicity is an important mechanism in neurodegenerative diseases, and it induces neuronal alterations similar to those observed in advanced MS, cortical neurons cultures were treated with different concentrations of glutamate (25, 50, 100, 200 and 500 µM) for 24 hours. After the treatment cortical neurons show a suffering appearance, with damaged axons and cellular degeneration. Neuronal viability, assessed by DAPI staining and by count of viable cells, was glutamate dose-dependent. In order to evaluate the possible positive effect of MSCs on neuronal survival, both direct and indirect co-cultures of MSCs and cortical neurons were set up, and the survival after glutamate treatment analyzed. Cortical neurons treated with glutamate were still suffering after the direct co-cultures with MSCs, while in indirect co-cultures with MSCs neurons were alive, without important signs of axonal degeneration. These preliminary findings suggest that MSCs are able to reduce the cellular death induced by glutamate exposure in cortical neurons and encouraged the further study and characterization of their positive effect
- Published
- 2011
41. ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation
- Author
-
DONZELLI, ELISABETTA, BALLARINI, ELISA, SCUTERI, ARIANNA, CARINI, FABRIZIO, TREDICI, GIOVANNI, MILOSO, MARIAROSARIA, Foudah, D, Caldara, C, Donzelli, E, Ballarini, E, Scuteri, A, Foudah, D, Caldara, C, Carini, F, Tredici, G, and Miloso, M
- Subjects
ERK ,Mesenchymal Stem Cell ,U0126 ,BIO/16 - ANATOMIA UMANA ,Adipogenic Differentiation ,Adipocytes Biology ,Mesenchymal Stem Cells - Abstract
Aims In order to develop therapeutic strategies to control obesity and the related pathologies, it is very important to deepen the knowledge of adipocytes biology and the mechanisms that control adipogenesis. In the present work we have studied the molecular mechanisms at the basis of the adipocytes differentiation using the human Mesenchymal Stem Cells (hMSCs), undifferentiated stem cells present in the bone marrow that are the physiological precursors of adipocytes in the organism. In particular we have focused our attention on the MAPKinases ERK1 and ERK2, that are involved in many biological and cellular processes. Methods hMSCs, obtained from iliac crest bone marrow, were induced to adipogenic differentiation by treatment with Adipogenic Induction Medium for 10 days (determination phase), then replaced with Adipogenic Maintenance Medium until the end of treatment at day 28 (terminal differentiation phase). hMSC adipogenic differentiation was evaluated by morphological and molecular techniques. Control cells were represented by hMSCs cultured in absence of adipogenic supplements. ERK1 and ERK2 expression and phosphorylation were evaluated by immunoblotting experiments. The specific ERK inhibitor U0126 was added to the adipogenic medium at different times during the adipogenic differentiation protocol. Results hMSC treated with adipogenic differentiation protocol showed lipid droplets that increased in number and size during the whole differentiation period. In treated hMSC both ERK1 and ERK2 phosphorylation was reduced in comparison to control hMSCs, but time and intensity of these reductions were different for the two isoforms. A decrease of the total amount of ERK1 was also observed. The presence of U0126 during the whole differentiation period hampered the adipogenic differentiation of hMSCs, as very few hMSCs showed the appearance of lipid droplets that were reduced both in number and size. When U0126 was administered only during the determination phase the number of hMSCs recruited in the differentiation program was reduced, while when U0126 was administered only in the terminal differentiation phase, hMSCs did not acquired a mature adipocytic phenotype. Conclusion In this work we demonstrate that ERK1 and ERK2 are important for hMSC adipogenic differentiation. Our results suggest that ERK1 and ERK2 play a key role in determining how many cells enter into the adipogenic differentiation program and acquire the phenotipycal and molecular characteristics of mature adipocytes.
- Published
- 2010
- Full Text
- View/download PDF
42. Transplanted pancreatic islets survive and reverse type I diabetic neuropathy
- Author
-
Marmiroli, Paola, Bianchi, Roberto, Figliuzzi, Marina, Scuteri, Arianna, Carozzi, Valentina, Canta, Annalisa, Meregalli, Cristina, Avezza, Federica, Miloso, Mariarosaria, Lauria, Giuseppe, Remuzzi, Andrea, Marmiroli, P, Bianchi, R, Figliuzzi, M, Scuteri, A, Carozzi, V, Canta, A, Meregalli, C, Avezza, F, Miloso, M, Lauria, G, and Remuzzi, A
- Subjects
Diabetic neuropathy ,BIO/16 - ANATOMIA UMANA ,Pancreatic Islet - Abstract
Type 1 diabetes is a chronic disease often leading to systemic complications, such as peripheral neuropathy, nephropathy and cardiovascular complications. Whole pancreas as well as pancreatic islets transplantation has been proposed for the cure of type 1 diabetes, allowing a more efficient and physiological metabolic control. We investigated the effects of microencapsulated and immunoisolated islet transplantation in a model of streptozotocin-induced diabetes in 3 groups of Lewis rats: healthy controls, untreated diabetic rats and diabetic rats transplanted with microencapsulated islets into the peritoneal cavity two months after diabetes induction. Our results demonstrated that following transplantation hyperglycemic rats became normoglycemic in few days and this was accompanied by a rapid raise in body weight. Meanwhile, thermal (hot plate test) and mechanical sensitivity (Randal-Selitto paw withdrawal test measured with an analgesymeter) were increased and decreased by 180 and 40-60%, respectively. In addition, the density of footpad intraepidermal nerve fibers was significantly reduced by 20% in diabetic group and islet transplantation restored normal skin innervation. Nerve conduction velocity in the tail nerve and the Na+, K+-ATPase activity in the sciatic nerve, both reduced by about 25% in diabetic rats, were also normalized by islet transplantation. In conclusion, our data obtained in a model of type 1 diabetes, showed that transplant of microencapsulated pancreatic islets, besides controlling glycemia, arrested neuropathy worsening and was able to restore all the diabetic-induced alterations within the 2-month follow-up period after transplantation. On the basis of these encouraging results, a new experiment with 4-month long diabetes followed-up for 4 months after allogenic transplantation has been performed and the preliminary analysis confirmed the effectiveness of the procedure also in these long-term diabetic animals. In fact, effective treatment of the peripheral nervous system damage was demonstrated at the behavioral and neurophysiological levels and the viability of the transplanted cells could be demonstrated until the end of the study at the functional and morphological levels. We believe that these data can offer a solid basis for the future implementation of more sophisticated models of diabetes treatment based on cellular transplantation.
- Published
- 2010
43. MSCs promote neuronal survival through NGF receptor regulation
- Author
-
SCUTERI, ARIANNA, PASINI, SILVIA, RAVASI, MADDALENA, RODRIGUEZ MENENDEZ, VIRGINIA, DONZELLI, ELISABETTA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, Scuteri, A, Pasini, S, Ravasi, M, RODRIGUEZ MENENDEZ, V, Donzelli, E, Miloso, M, and Tredici, G
- Subjects
MSCs, neuronal survival,NGF receptor ,BIO/16 - ANATOMIA UMANA - Published
- 2010
44. Mesengenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells
- Author
-
Scuteri, A, Donzelli, E, Foudah, D, Caldara, C, Redondo, J, D'Amico, G, Tredici, G, Miloso, M, SCUTERI, ARIANNA, DONZELLI, ELISABETTA, FOUDAH, DANA, CALDARA, CRISTINA, REDONDO, JULIANA, TREDICI, GIOVANNI, MILOSO, MARIAROSARIA, Scuteri, A, Donzelli, E, Foudah, D, Caldara, C, Redondo, J, D'Amico, G, Tredici, G, Miloso, M, SCUTERI, ARIANNA, DONZELLI, ELISABETTA, FOUDAH, DANA, CALDARA, CRISTINA, REDONDO, JULIANA, TREDICI, GIOVANNI, and MILOSO, MARIAROSARIA
- Abstract
Background and Objectives: Cellular therapies using Mesenchymal Stem Cells (MSCs) represent a promising approach for the treatment of degenerative diseases, in particular for mesengenic tissue regeneration. However, before the approval of clinical trials in humans, in vitro studies must be performed aimed at investigating MSCs' biology and the mechanisms regulating their proliferation and differentiation abilities. Besides studies on human MSCs (hMSCs), MSCs derived from rodents have been the most used cellular type for in vitro studies. Nevertheless, the transfer of the results obtained using animal MSCs to hMSCs has been hindered by the limited knowledge regarding the similarities existing between cells of different origins. Aim of this paper is to highlight similarities and differences and to clarify the sometimes reported different results obtained using these cells. Methods and Results: We compare the differentiation ability into mesengenic lineages of rat and human MSCs cultured in their standard conditions. Our results describe in which way the source from which MSCs are derived affects their differentiation potential, depending on the mesengenic lineage considered. For osteogenic and chondrogenic lineages, the main difference between human and rat MSCs is represented by differentiation time, while for adipogenesis hMSCs have a greater differentiation potential. Conclusions: These results on the one hand suggest to carefully evaluate the transfer of results obtained with animal MSCs, on the other hand they offer a clue to better apply MSCs into clinical practice
- Published
- 2014
45. Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1
- Author
-
Rigolio, R, Cadamuro, M, Caramia, G, Malacrida, A, Maggioni, D, Foudah, D, Miloso, M, RIGOLIO, ROBERTA, CADAMURO, MASSIMILIANO, MALACRIDA, ALESSIO, MAGGIONI, DANIELE, FOUDAH, DANA, MILOSO, MARIAROSARIA, Rigolio, R, Cadamuro, M, Caramia, G, Malacrida, A, Maggioni, D, Foudah, D, Miloso, M, RIGOLIO, ROBERTA, CADAMURO, MASSIMILIANO, MALACRIDA, ALESSIO, MAGGIONI, DANIELE, FOUDAH, DANA, and MILOSO, MARIAROSARIA
- Abstract
Cholangiocarcinoma (CCA) is the second most frequent primary liver neoplasia. It mainly arises from the malignant transformation of biliary epithelial cells, although it might originate from either hepatic progenitor cells at the Hering canals or transformed hepatocytes. CCA is a highly aggressive tumor with extremely poor prognosis and limited therapeutic approaches. Baicalin (BA) is one of the main bioactive flavonoids identified in the Scutellaria Baicalensis Georgi root dried extract which is extensively used in the Chinese tra-ditional medicine. Together with the anti-inflammatory effect, the anti-neoplastic action is the most relevant BA property demonstrated on cancer cells of different origin. Being aware of the need of new therapeutic weapons for CCA treatment, we in-vestigated whether Baicalin could exert anti-proliferative and anti-migratory effect on EGI-1 cells, a highly metastatic CCA cell line derived from bile duct carcinoma. We first tested different BA concentrations (from 5 to 200µM) in limiting EGI-1 via-bility using MTT assay. After 24h and 48h treatment, 5 and 10µM BA had no effect while rising from 25µM to 200µM (i.e. 25,50,100 and 200µM) BA exerted a significant cell viability reduction already at 24h and increased after 48h BA expo-sure. This reduction well correlated with the adherent absolute cell number de-crease and it cannot be due to BA induced cell cycle impairment after neither 24 nor 48h treatment. We also evaluated the anti-migratory BA potential by a wound healing assay adding different BA concentrations (5, 25, 50,100 and 200µM) to the culture medium immediately after performing a wound on confluent cell cultures. All BA concen-trations but 5µM induced a significant reduction in the EGI-1 migration rate after 24h treatment. Moreover 25, 50 and 10µM BA showed similar migration inhibition extent at 24 and 48h whilst 200µM BA exerted a stronger inhibitory effect already after 24h exposure which increased with time in a significant w
- Published
- 2014
46. Mesengenic Differentiation: Comparison of Human and Rat Bone Marrow Mesenchymal Stem Cells
- Author
-
Scuteri, Arianna, primary, Donzelli, Elisabetta, additional, Foudah, Dana, additional, Caldara, Cristina, additional, Redondo, Juliana, additional, D’Amico, Giovanna, additional, Tredici, Giovanni, additional, and Miloso, Mariarosaria, additional
- Published
- 2014
- Full Text
- View/download PDF
47. Confocal laser scanning microscope and ultrastructural study of the intracellular localization of fluorescein-loaded mesoporous silica carriers
- Author
-
CAVALETTI, GUIDO ANGELO, CERESA, CECILIA, NICOLINI, GABRIELLA, MILOSO, MARIAROSARIA, Cundari, S, Pasqua, L., Cavaletti, G, Ceresa, C, Nicolini, G, Miloso, M, Cundari, S, and Pasqua, L
- Subjects
mesoporous silica nanoparticles, microscopy, drug targeting ,BIO/16 - ANATOMIA UMANA - Abstract
Mesoporous silica particles (MSP) are a new development in nanotechnology. Covalent modification of the surface of the silica is possible both on the internal pore and on the external particle surface. It allows the design of functional nanostructured materials with properties of organic, biological and inorganic components. Research and development are ongoing on the MSP, which have applications in catalysis, drug delivery and imaging. The most recent and interesting advancements in size, morphology control and surface functionalization of MSP have enhanced the biocompatibility of these materials with high surface areas and pore volumes. In the last 5 years several reports have demonstrated that MSP can be efficiently internalized using in vitro and animal models. The functionalization of MSP with organic moieties or other nanostructures brings controlled release and molecular recognition capabilities to these mesoporous materials for drug/gene delivery and sensing applications, respectively. In this study different MSP have been tested: silica-FITC MSP and silica-folate-FITC MSP. Folic acid was used as the targeting ligand because -folate receptor is observed to be up-regulated in various types of human cancers. We have evaluated by confocal laser scanning microscopy (CLSM) the intracellular localization of FITC-loaded MSP in two different cancer cell lines: IGROV-1 (ovarian carcinoma) and A549 (lung adenocarcinoma) characterized by a different expression of folate receptor alpha. Our results demonstrate that silica nanoparticles localize into the cytoplasm of A549 and IGROV-1 cell lines after 1, 6 and 24 hours of treatment and present a perinuclear localization. Additionally the treated cells were examined cross-sectionally in order to confirm that the MSP were indeed internalized by the cells and not simply bound on the surface membrane. Flow cytometry was used for the quantification of fraction of cells that had internalized nanoparticles. The cellular uptake of silica nanoparticles was observed with both cell lines and folate modification on the silica nanoparticles increased the particles uptake by A549 and IGROV-1 cells. The over-expression of folate receptor may facilitate the recognition of the folate-modified nanoparticles and increase the uptake through folate receptor-mediated endocytosis Electron microscopy experiments also confirmed that silica nanoparticles are able to enter into tumor cells. The particles are progressively internalized into the cell cytoplasm starting from 15 minutes after treatment and after 30 minutes are completely internalized.
- Published
- 2009
48. Mechanisms of DRG neurons and MSC interactions in co-culture
- Author
-
SCUTERI, ARIANNA, PASINI, SILVIA, RAVASI, MADDALENA, RODRIGUEZ MENENDEZ, VIRGINIA, BOSSI, MARIO, DONZELLI, ELISABETTA, MILOSO, MARIAROSARIA, TREDICI, GIOVANNI, Scuteri, A, Pasini, S, Ravasi, M, RODRIGUEZ MENENDEZ, V, Bossi, M, Donzelli, E, Miloso, M, and Tredici, G
- Subjects
BIO/16 - ANATOMIA UMANA ,DRG neurons, MSC, co-culture - Published
- 2009
49. MAPKs role in human Mesenchymal Stem Cells adipogenic differentiation
- Author
-
DONZELLI, ELISABETTA, MAGGIONI, DANIELE, NICOLINI, GABRIELLA, MILOSO, MARIAROSARIA, Lucchini, C, Donzelli, E, Lucchini, C, Maggioni, D, Nicolini, G, and Miloso, M
- Subjects
MAPKs, human Mesenchymal Stem Cells, adipogenic differentiation ,BIO/16 - ANATOMIA UMANA - Published
- 2008
50. Spontaneous exression of specific neural proteins by undifferentiated mesenchymal stem cells
- Author
-
FOUDAH, DANA, DONZELLI, ELISABETTA, SCUTERI, ARIANNA, RODRIGUEZ MENENDEZ, VIRGINIA, TREDICI, GIOVANNI, MILOSO, MARIAROSARIA, Foudah, D, Donzelli, E, Scuteri, A, RODRIGUEZ MENENDEZ, V, Tredici, G, and Miloso, M
- Subjects
BIO/16 - ANATOMIA UMANA ,Spontaneous exression,neural proteins, undifferentiated mesenchymal stem cells - Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.